This brand name is authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, France, Germany, Hong Kong SAR China, Ireland, Italy, Malta, Mexico, Netherlands, Nigeria, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug DIAMICRON contains one active pharmaceutical ingredient (API):
1
|
UNII
G4PX8C4HKV - GLICLAZIDE
|
|
Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| DIAMICRON MR Modified release tablet | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A10BB09 | Gliclazide | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 9302N |
| BR | Câmara de Regulação do Mercado de Medicamentos | 531300504111317, 531300602113314, 531300603111315, 531300604116310, 531300605112319 |
| CA | Health Products and Food Branch | 00765996, 02242987, 02356422 |
| DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 06488698, 06488706 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 29539-12-10, 29578-2-01-11 |
| ES | Centro de información online de medicamentos de la AEMPS | 63644, 71738 |
| FR | Base de données publique des médicaments | 60331738, 68419097, 68831670 |
| GB | Medicines & Healthcare Products Regulatory Agency | 138648, 143135, 14761, 161583, 36622, 36623 |
| HK | Department of Health Drug Office | 46779, 60658 |
| IE | Health Products Regulatory Authority | 46985, 69515, 69540 |
| IT | Agenzia del Farmaco | 023404092, 023404231, 045454016, 045630011, 045637016, 045637028 |
| MT | Medicines Authority | MA066/00601, MA066/00603, MA066/00604, PI1438/05001A, PI1438/05002A, PI521/07601A, PI770/10702A, PI770/10703A, PI908/00902A, PI908/00903A |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 022M2002 |
| NG | Registered Drug Product Database | A4-7426, B4-9083 |
| NL | Z-Index G-Standaard, PRK | 61530 |
| PL | Rejestru Produktów Leczniczych | 100135837 |
| SG | Health Sciences Authority | 04316P, 11761P, 13868P |
| TN | Direction de la Pharmacie et du Médicament | 6350013, 9163581, 9253881, 9253882 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699552030058, 8699552030065, 8699552030072, 8699552030089, 8699552030096 |
| ZA | Health Products Regulatory Authority | 35/21.2/0178, 43/21.2/0957 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.